Bicarbonate Variation Monitoring With Indirect Calorimetry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon

About this trial

Patients admitted to the intensive care unit frequently exhibit abnormal blood bicarbonate levels. These abnormalities are associated with patient outcomes and often prompt clinicians to modify management, either diagnostically or therapeutically (e.g., initiation or adjustment of mechanical ventilation, initiation or modification of extracorporeal renal replacement therapy, administration of specific diuretics, or sodium bicarbonate infusion).

Currently, the only way to determine blood bicarbonate concentration is through repeated blood sampling for laboratory analysis. However, this method is both discontinuous and invasive.

We have generated an in silico hypothesis suggesting that the mismatch between cellular CO₂ production/elimination and pulmonary CO₂ elimination reflects changes in blood bicarbonate levels. We propose to test this hypothesis in a cohort of intensive care unit patients.

If confirmed, indirect calorimetry could be positioned as a continuous, non-invasive monitoring tool for blood bicarbonate.

Eligibility criteria

Qualifiers

Adult patient admitted to the ICU within the past 72 hours

Receiving invasive mechanical ventilation

For whom the treating clinician plans to perform at least two blood bicarbonate measurements within the next 6 hours

No objection from the participant or their next of kin

Disqualifiers

Planned weaning from invasive mechanical ventilation or ventilator change before the second bicarbonate measurement

Inspiratory oxygen fraction > 60%

Administration of inhaled medications, including nitric oxide

Positive end-expiratory pressure (PEEP) > 15 cmH₂O

Trial design

Treatments tested in this trial

  • Indirect calorimetry measurement

Treatment groups

91 Participants
are divided into 1 treatment group

Sponsors and collaborators